Medicare spending analysis for Hematopoietic Cell Transplantation and Cellular Therapy providers
Hematopoietic Cell Transplantation and Cellular Therapy accounts for $89.6M in Medicare payments across 985 providers.
The specialty's average markup of 4.0x is above the overall Medicare average of 3.77x.
AI-generated analysis based on Medicare payment data.
| Year | Payments | Services | Providers | YoY Change |
|---|---|---|---|---|
| 2018 | $14.6M | 806.7K | 166 | — |
| 2019 | $16.3M | 870.0K | 175 | +11.3% |
| 2020 | $14.7M | 614.7K | 173 | -9.6% |
| 2021 | $16.5M | 656.1K | 162 | +11.9% |
| 2022 | $14.9M | 679.2K | 159 | -9.2% |
| 2023 | $12.7M | 510.6K | 150 | -15.2% |
| # | Provider | State | Payments | Services | Avg/Service |
|---|---|---|---|---|---|
| 1 | Lisa Sproat | AZ | $1.9M | 101.3K | $18.56 |
| 2 | Ernesto Ayala | FL | $1.7M | 110.1K | $15.62 |
| 3 | Jeanne Palmer | AZ | $731.7K | 27.1K | $26.97 |
| 4 | Jose Leis | AZ | $702.4K | 37.7K | $18.61 |
| 5 | Nandita Khera | AZ | $537.7K | 24.8K | $21.68 |
| 6 | Michael Maris | CO | $480.2K | 13.2K | $36.40 |
| 7 | James Essell | OH | $475.7K | 34.0K | $14.00 |
| 8 | Racquel Innis-Shelton | AL | $422.7K | 62.8K | $6.73 |
| 9 | Tara Gregory | CO | $420.5K | 11.4K | $36.85 |
| 10 | Michael Tees | CO | $394.0K | 10.8K | $36.48 |
| 11 | Gary Simmons | VA | $176.5K | 23.3K | $7.57 |
| 12 | George Geils | SC | $122.0K | 1.3K | $91.52 |
| 13 | Seth Maliske | IA | $87.0K | 1.2K | $72.00 |
| 14 | Peter Forsberg | CO | $85.0K | 929 | $91.48 |
| 15 | Sebastian Alexander Mayer | NY | $79.4K | 738 | $107.54 |
| 16 | Muzaffar Qazilbash | TX | $75.2K | 731 | $102.85 |
| 17 | Yvonne Efebera | OH | $71.2K | 666 | $106.87 |
| 18 | Benjamin Derman | IL | $69.5K | 622 | $111.78 |
| 19 | Henry Fung | PA | $69.1K | 655 | $105.49 |
| 20 | Larry Anderson | TX | $67.6K | 778 | $86.92 |
| 21 | John Edwards | IN | $66.0K | 909 | $72.65 |
| 22 | Mehmet Kocoglu | MD | $65.7K | 712 | $92.22 |
| 23 | Ashraf Badros | MD | $61.9K | 645 | $95.93 |
| 24 | Uday Popat | TX | $61.4K | 714 | $86.06 |
| 25 | Matthew Zibelman | PA | $60.9K | 646 | $94.25 |
| Code | Description | Payments | Services | Avg/Service |
|---|---|---|---|---|
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | $2.6M | 68.9K | $37.74 |
| J9271 | Injection, pembrolizumab, 1 mg | $1.9M | 45.6K | $41.69 |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | $1.6M | 13.7K | $114.80 |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | $1.5M | 15.8K | $94.97 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | $1.3M | 16.9K | $75.91 |
| J9299 | Injection, nivolumab, 1 mg | $562.9K | 24.9K | $22.57 |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | $459.6K | 13.7K | $33.67 |
| J0897 | Injection, denosumab, 1 mg | $249.2K | 13.5K | $18.46 |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | $220.5K | 1.5K | $143.84 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | $207.3K | 2.1K | $96.51 |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | $186.9K | 3.7K | $51.04 |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | $186.2K | 5.2K | $35.54 |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | $180.7K | 8.3K | $21.72 |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | $172.7K | 2.8K | $61.60 |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | $114.5K | 860 | $133.20 |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | $108.5K | 11.3K | $9.60 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | $96.4K | 40.8K | $2.36 |
| J9173 | Injection, durvalumab, 10 mg | $93.3K | 1.7K | $56.43 |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | $73.9K | 551 | $134.13 |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | $62.2K | 573 | $108.52 |
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.